OxyContin OC 60mg – The Complete Medical Guide
OxyContin OC 60mg is a high-potency extended-release oxycodone formulation classified as a Schedule II controlled substance. This pre-reformulation version (lacking modern abuse-deterrent properties) is reserved for severe, around-the-clock pain in highly opioid-tolerant patients. The “OC” designation indicates it can be more easily manipulated for abuse compared to current “OP” formulations.
Oxycontin OC 60mg
OxyContin OC 60mg is a powerful prescription opioid painkiller used to manage severe, long-term pain. Formulated with extended-release technology, it provides consistent pain relief over an extended period, making it ideal for patients with chronic pain conditions. The active ingredient, oxycodone, works by altering the way the brain and nervous system respond to pain. Due to its potency, OxyContin OC 60mg is prescribed with caution and should be used only under a doctor’s supervision to prevent misuse, addiction, or overdose. Always follow prescribed dosage instructions for safety and effectiveness.
Medical Uses & Indications
FDA-Approved Uses
Severe chronic pain requiring continuous opioid therapy
Cancer pain management in opioid-tolerant patients
Pain uncontrolled by lower-dose opioids
Key Clinical Features
• Formulation: Original controlled-release (non-abuse deterrent)
• Onset: 1-2 hours
• Duration: 12-hour controlled release
• Equianalgesic ratio: 60mg q12h ≈ 90mg oral morphine daily
• DEA Classification: Schedule II (Highest abuse potential)
Pharmacology & Mechanism
Neurochemical Action
• Full μ-opioid receptor agonist
• κ-opioid receptor partial agonist
• Potent activation of reward pathways
Metabolic Profile
• Hepatic metabolism: CYP3A4 (major), CYP2D6 (minor)
• Active metabolites: Oxymorphone (via CYP2D6)
• Elimination half-life: 4.5-8 hours (ER formulation)
Dosing & Administration
Strict Eligibility Criteria
• Confirmed opioid tolerance: ≥120mg oral morphine equivalent daily
• Stable pain pattern
• Failed trials of abuse-deterrent formulations
Conversion Protocol
-
Calculate total daily morphine equivalent
-
Reduce by 25-50% (incomplete cross-tolerance)
-
Divide by 2 for q12h dosing
Critical Safety Notes
Hospital initiation strongly recommended
Never crush/chew tablets (immediate 60mg release risk)
Requires dual prescriber verification
Naloxone rescue kit mandatory
Safety Profile
Common Adverse Effects
• Severe constipation
• Nausea/vomiting
• Profound sedation
• Cognitive impairment
Black Box Warnings
Extreme addiction potential
Life-threatening respiratory depression
Fatal overdose risk if misused
Concomitant CNS depressant danger
Risk Mitigation Strategies
Prescribing Safeguards
-
Specialist pain management consultation
-
Triplicate prescription forms where required
-
Weekly follow-ups initially
-
Random pill counts and UDS
Patient Safety Measures
• Biometric locked storage
• Mandatory caregiver training
• Medication disposal system
• Absolute alcohol prohibition
Clinical Alternatives
For Severe Chronic Pain
• OxyContin OP (abuse-deterrent)
• Methadone (For select patients)
• Fentanyl transdermal
Non-Opioid Options
• Intrathecal pump therapy
• Dorsal column stimulation
• Adjuvant medications
Special Population Considerations
| Population | Consideration | Action |
|---|---|---|
| Elderly (≥65) | CONTRAINDICATED | – |
| Hepatic impairment | CONTRAINDICATED | – |
| Renal (CrCl<30) | CONTRAINDICATED | – |
| Pediatric | CONTRAINDICATED | – |